Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Clinical trial NCT06816966 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06816966
- Sponsor
- Fujian Medical University Union Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-26
- Primary completion
- 2026-10-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.